BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29432844)

  • 1. Pharmacogenomics signature: A novel strategy on the individual differences in drug response.
    Guo C; Lin X; Yin J; Xie X; Li J; Meng X; Wu J; Huang L; Huang Z; Yang G; Zhou H; Chen X
    Cancer Lett; 2018 Apr; 420():190-194. PubMed ID: 29432844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine.
    Ahmed S; Zhou Z; Zhou J; Chen SQ
    Genomics Proteomics Bioinformatics; 2016 Oct; 14(5):298-313. PubMed ID: 27729266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized Medicine: Pharmacogenomics and Drug Development.
    Mirsadeghi S; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):150-165. PubMed ID: 28282716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Promise of Pharmacogenomics: Genetic variation can be used to individualize drug therapy, and is an integral component of genomic medicine.
    Am J Med Genet A; 2019 Dec; 179(12):2324-2325. PubMed ID: 31709748
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.
    Auman JT; McLeod HL
    Drug Metab Rev; 2008; 40(2):303-15. PubMed ID: 18464047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics of Antibiotics.
    Stocco G; Lucafò M; Decorti G
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
    Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
    Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics, precision medicine, and implications for anesthesia care.
    Kaye AD; Mahakian T; Kaye AJ; Pham AA; Hart BM; Gennuso S; Cornett EM; Gabriel RA; Urman RD
    Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):61-81. PubMed ID: 30322465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases.
    Chaudhary R; Singh B; Kumar M; Gakhar SK; Saini AK; Parmar VS; Chhillar AK
    Drug Metab Rev; 2015 Aug; 47(3):281-90. PubMed ID: 25996670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics and pharmacogenomics: development, science, and translation.
    Weinshilboum RM; Wang L
    Annu Rev Genomics Hum Genet; 2006; 7():223-45. PubMed ID: 16948615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering next-generation pharmacogenomics: an information technology perspective.
    Potamias G; Lakiotaki K; Katsila T; Lee MT; Topouzis S; Cooper DN; Patrinos GP
    Open Biol; 2014 Jul; 4(7):. PubMed ID: 25030607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PGX: Pharmacogenomics During Generation X.
    Yee J
    Adv Chronic Kidney Dis; 2016 Mar; 23(2):57-60. PubMed ID: 26979142
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy.
    Roosan D; Hwang A; Roosan MR
    Pharmacogenomics J; 2021 Feb; 21(1):1-7. PubMed ID: 32843688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics: Precision Medicine and Drug Response.
    Weinshilboum RM; Wang L
    Mayo Clin Proc; 2017 Nov; 92(11):1711-1722. PubMed ID: 29101939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Pain Management with Pharmacogenomics: A General Introduction.
    Schuh MJ; Randles H; Crosby S
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):114-119. PubMed ID: 32186418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials in pharmacogenetics and pharmacogenomics: methods and applications.
    Rioux PP
    Am J Health Syst Pharm; 2000 May; 57(9):887-98; quiz 899-901. PubMed ID: 10840530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenes (PGx-genes): Current understanding and future directions.
    Katara P; Yadav A
    Gene; 2019 Nov; 718():144050. PubMed ID: 31425740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic pharmacogenomics analysis of a Malay whole genome: proof of concept for personalized medicine.
    Salleh MZ; Teh LK; Lee LS; Ismet RI; Patowary A; Joshi K; Pasha A; Ahmed AZ; Janor RM; Hamzah AS; Adam A; Yusoff K; Hoh BP; Hatta FH; Ismail MI; Scaria V; Sivasubbu S
    PLoS One; 2013; 8(8):e71554. PubMed ID: 24009664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
    Cecchin E; De Mattia E; Ecca F; Toffoli G
    Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.